Skip to main content
. 2020 Mar 2;37(4):1522–1535. doi: 10.1007/s12325-020-01257-6
Why carry out this study?
Despite the availability of innovative and effective biological agents for rheumatic diseases, patients may not experience the full benefits of treatment because of poor medication adherence
The CIMZIA® AutoClicks® pre-filled pen (CZP PFP) was developed to overcome barriers to self-injection, by improving self-injection confidence, reducing fear associated with needle use, and supporting patients with impaired dexterity
The purpose of this research was to gather feedback on injection experience and the usefulness of training materials
What was learned from the study?
After training, patients generally found the device easy to use and showed high confidence and satisfaction with self-injection
Increasing self-injection experience, together with patient training and continued support, may have facilitated high patient confidence and satisfaction, thereby potentially overcoming some of the barriers to self-injection